EPC Leadership

Dr. Kliger is a Clinical Professor of Medicine, Yale University School of Medicine. He served formerly as Senior Vice President Medical Affairs, Chief Quality Officer, Yale New Haven Health System and Senior Vice President, Chief Medical Officer, Hospital of Saint Raphael, New Haven Connecticut. He is a past president of the Renal Physicians Association, and serves on its Quality, Safety and Accountability Committee. He is a past president of the Forum of ESRD Networks. He served as chair of the steering committees for the NIH Frequent Hemodialysis Study, and NIH/NIDDK Consortium on Novel Therapies for Hemodialysis Patients. Dr. Kliger currently chairs ASN’s Excellence in Patient Care Advisory Panel.

Dr. Bryant joined the University of Louisville School of Medicine faculty in 2000 and is currently a Professor of Pediatrics in the Division of Pediatric Infectious Diseases. Since 2008, she has directed the Pediatric Infectious Diseases Fellowship Program at U of L. She is currently the President-elect of the Pediatric Infectious Diseases Society, the world’s largest organization of professionals dedicated to the treatment, control, and eradication of infectious diseases affecting children.

Dr. Bryant is the hospital epidemiologist at Norton Children’s Hospital and a member of the leadership team that coordinates infection prevention and control efforts at Norton Healthcare. She is active in state-wide efforts to prevent healthcare-associated infections and is a member of  the Kentucky State Regional Infection Prevention and Epidemiology (K-STRIPE) committee. She is a former chair of the Society for Healthcare Epidemiology of America Guidelines Committee and has co-authored several infection prevention guideline/guidance documents. She is the co-editor of a book, Handbook of Pediatric Infection Prevention and Control, scheduled for publication this spring. In December 2016, Dr. Bryant was appointed by the Secretary of Health and Human Services to the Healthcare Infection Control Practices Advisory Committee (HICPAC), a federal advisory committee that provides advice and guidance to the Centers for Disease Control and Prevention (CDC) regarding strategies for surveillance and prevention and control of health care associated infections in United States health care facilities.

Dr. Delgado is a Professor of Medicine at the University of California, San Francisco. Dr. Delgado is a leader in kidney care innovation. She sits on the leadership committee of the Transforming Dialysis Access Together (TDAT) initiative and chairs the Fostering Innovative Leaders in Nephrology and Dialysis (FIND) program at ASN. She also contributed to the joint ASN-NKF Task Force that developed a race-free approach to estimating kidney function. In recognition of her contributions, Dr. Delgado was named one of Time Magazine’s Top 100 most influential people in health in 2024. Her research focuses on the intersection of chronic kidney disease, quality of life, and clinical outcomes-based research.

Dr. Alessia Fornoni is a Professor of Medicine, Molecular and Cellular Pharmacology, and Biochemistry at the University of Miami Miller School of Medicine. She serves as the Director and Chair of the Peggy and Harold Katz Drug Discovery Center. Dr. Fornoni gained experience in drug development at Hoffmann-La Roche in Basel and is the founding scientist of several start-up companies. Her research is supported by grants from the NIH, industry, and private foundations.

She has received numerous prestigious awards, including membership in the American Society of Clinical Investigation (ASCI, 2017), the Association of American Physicians (AAP, 2021), and the Florida Academy of Science, Engineering, and Medicine (ASEMFL, 2023). Dr. Fornoni serves on the editorial boards of the Journal of Clinical Investigation and Kidney International and was the Deputy Editor of JASN in 2024. She began her term as the At-Large Councilor for the ASN Council in January 2025.

As a recipient of multiple mentorship awards, Dr. Fornoni has guided trainees who now hold leadership positions in academic institutions worldwide. As the Assistant Dean for Research Training and Development, Co-Director of the MD/PhD MSTP program and the CTSI K12 program, and Director of an NIH-funded summer school in Nephrology, she is deeply committed to mentoring students and junior faculty on their paths to successful academic careers.

Through her pioneering work on insulin signaling, cholesterol metabolism, and sphingolipid-related pathways, Dr. Fornoni has uncovered novel pathogenetic mechanisms and therapeutic approaches for glomerular disorders, which have successfully progressed to ongoing clinical trials. She serves as a grant reviewer for the Alport Foundation.

Dr. Garrick is a practicing nephrologist with over 40 years’ experience. She is the Executive Medical Director of Westchester Medical Center, a public benefit hospital, and Chief Medical Officer of Westchester Health Network, a 1,700 bed academic health system with hospitals and offices in the Westchester and the Hudson Valley. As CMO of Westchester Health Network, she oversees quality, safety, and regulatory initiatives for the Health Network, and has extensive experience with quality initiatives as they relate to patients with kidney disease. She currently serves as the medical director of a non-profit dialysis facility and previously chaired the NY State’s taskforce on dialysis care. She serves on the Quality Steering Committee of Healthcare Association of New York State (HANYS), and on the New York State Department of Health Quality Advisory Committee for Office Based Surgery. She is the prior co-chair of the NQF Renal Standing Committee and has served on NQF Technical expert panels. She has participated in the creation of Patient Related Outcome Measures for patients with kidney disease. Additionally, she has served on the Divisional Board of IPRO- ESRD Network of New York, and is a past board member of the Renal Physicians Association, where she currently serves on the Quality, Safety and Accountability Committee. She is a member of the ASN Nephrologist Transforming Dialysis Safety Workgroup and serves on a Data and Safety Monitoring Board of the NIH/NIDDK.

Keisha L. Gibson, MD, is Clinical Associate Professor of Medicine and Pediatrics and Chief of Pediatric Nephrology in the Division of Nephrology and Hypertension at the University of North Carolina at Chapel Hill. She is also the Vice Chair of Equity and Community Engagement for the Department of Medicine. Dr. Gibson received her medical degree and Masters of Public Health degree in epidemiology from UNC Chapel Hill. She completed a residency in general pediatrics at MUSC in Charleston and fellowship in pediatric nephrology from UNC Chapel Hill. She is board certified in pediatrics and pediatric nephrology. Her research and clinical interests focus on lupus nephritis and other glomerular diseases. In the area of epidemiology, she is interested in ethnic and socioeconomic disparities and their effect on patient outcomes. She has been involved as a co-investigator with large consortium studies such as the Nephrotic Syndrome Network Study (Neptune Study) and the Cure Glomerulonephropathy Network (Cure GN Study). Within the ASN, Dr. Gibson has served in several capacities. Dr. Gibson currently chairs the Glomerular Diseases Collaborate (GD-C) Steering Committee for ASN, and is a member of many GD-C workgroups.

Alp Ikizler, MD is the Director of Division of Nephrology and Hypertension, Catherine MacLaughlin-Hakim Chair in Vascular Biology and Professor of Medicine at the Vanderbilt University School of Medicine in Nashville, Tennessee. His clinical and research activities are focused on improving the clinical outcomes and quality of life in patients with acute and chronic kidney disease.

Jay L. Koyner, MD, is a Professor of Medicine in the Section of Nephrology at the University of Chicago. He completed his undergraduate degree in Biophysics at Johns Hopkins University. He then went on to complete medical school at the State University of New York at Stony Brook where he awarded a degree with distinction in research following completion of an additional year for a Howard Hughes Medical Institute Research Fellowship. Dr. Koyner completed his internal medicine and nephrology training at the University of Chicago, where he currently serves as the Medical Director of the Inpatient Dialysis Unit and Director of ICU Nephrology. His critical care nephrology research interests have focused on the utilization of plasma and urine biomarkers to improve patient risk stratification and outcomes in the setting of AKI. Additionally, Dr. Koyner has contributed to several multicenter facilities investigating the biomarkers of AKI, including the TRIBE-AKI study and the Furosemide Stress Test. Current research interests using the electronic health record to develop AKI risk scores to improve the care of patients with early AKI and improving AKI therapeutics. Dr. Koyner has published over 200 peer-reviewed articles and book chapters on AKI and the care of patients with kidney injury in the ICU.

Dr Levin is a Professor of Medicine, Head, Division of Nephrology at the University of British Columbia, and Consultant nephrologist at Providence Health Care/ St Paul’s Hospital, in Vancouver Canada.

She is the Executive Director of the BC Renal Agency, which oversees the care, planning and budgets for Kidney services in the province of British Columbia

She is active in international activities across the spectrum of kidney activities and has served as in leadership roles at the International Society of Nephrology (ISN), as President (2015-17), and is Chair of the ISN ACT (Advancing clinical Trials) Committee. She was one of the founding members of the Declaration of Istanbul Custodian Group (DICG), serving as one of the first Co-Chairs of that Group.
Her major research interests include non- traditional risk factors for CVD in CKD patients and progression of CKD variability, as well as models of care. She has over 1000 peer reviewed publications, and numerous book chapters. She is the Principal Investigator on a large national patient-oriented research network grant CAN SOLVE CKD. She collaborates with investigators across Canada and internationally.

She has received numerous teaching and research awards, from Canadian Society of Nephrology, Kidney Foundation of Canada, British Columbia Health Research Institute and is a Fellow of Canadian Academy of Health Sciences, and was awarded the highest civilian honour, The Order of Canada in 2015. She was the recipient of the ISN Jean Hamburger Award in 2024 and most recently in March she received the King Charles III Coronation Medal.

Ryan McDevitt is a Professor of Economics at Duke University and a Research Associate in the Health Care Program of the National Bureau of Economic Research. Prior to joining Duke, he held faculty positions at the University of Rochester’s Simon School of Business and Northwestern University’s Kellogg School of Management, and was an investment banking analyst at Morgan Stanley. He earned his B.A from Williams College and Ph.D. from Northwestern University, both in economics.

McDevitt’s research focuses on applied microeconomics, specifically on how health care providers respond to financial incentives, and has been published in the American Economic Review, the Journal of Political Economy, the Quarterly Journal of Economics, the Review of Economic Studies, and JAMA. His work has been funded by the Washington Center for Equitable Growth, the National Science Foundation, and the National Bureau of Economic Research, and the National Institute for Health Care Management. He has won teaching awards for his courses in economics, strategy, and econometrics.

Dana Mitchell MD, FACP, FASN is the CEO of Global Kidney Center, in Houston, Texas, with extensive experience in care and treatment of kidney diseases as well as a background in emergency care. In addition to practicing clinical medicine, she currently serves as an adviser to nephrology groups given her experience with managing small and large nephrology practices.

She currently serves as the Medicine Program Director and chairs the Nephrology Clinical Performance Committee for the Memorial Hermann Physician Network. She has chaired and served on a variety of professional panels focused on clinical performance, quality and medical ethics.

Dr. Mitchell received the Exemplary Nephrology Practice Award from the Renal Physicians Association, is listed as one of Houston’s top doctors, was selected by the International Association of Healthcare Professionals as a Top Nephrologist in Texas, and has received numerous other awards for her contributions to advancing treatment and care of people with kidney diseases. She is a highly sought-after speaker addressing a wide range of complex issues in nephrology care, including medication management, patient safety, and quality assessment.

Dr. Mitchell received her medical degree from Louisiana State University. She completed her internship and residency at Louisiana State University and her fellowship at the University of Alabama, Birmingham.

Vandana Dua Niyyar is Professor of Medicine in the Division of Nephrology and has received the Clinical Distinction of Master Physician at Emory University. Dr. Niyyar’s clinical interests center on kidney failure, with specific expertise in dealing with hemodialysis vascular access and renal ultrasonography. She currently serves as Immediate Past President of the American Society of Diagnostic and Interventional Nephrology (ASDIN), the Chair of the Transforming Dialysis Access Together (TDAT) initiative through an ASN-CDC cooperative agreement,  Steering Committee member of the Fostering Innovative Leaders in Nephrology and Dialysis (FIND) and Nephrologists Transforming Dialysis Safety projects through ASN.

Dr. Niyyar is passionate about promoting multidisciplinary collaboration in research and education in the field of HD vascular access; with the ultimate goal of optimizing access care and processes for dialysis patients. She enjoys teaching and has taught numerous didactic presentations and hands-on training workshops regionally, nationally, and internationally. Dr. Niyyar has been recognized for her exemplary clinical and service achievements through various awards including ASDIN Distinguished Service Award in 2019, Emory Nanette Wenger Service Award in 2019, American Society of Nephrology Mid-Career Distinguished Clinical Service Award 2020, American Nephrologists of Indian Origin Clinical Excellence Award in 2021,Emory DOM Outstanding Quality Achievement Award in 2022 and ASDIN Gerald Beathard Award in recognition of her teaching excellence, scholarly activity, and clinical excellence in 2024.

Dr. Chirag R. Parikh is a Professor of Medicine and the Director of the Division of Nephrology at the Johns Hopkins University School of Medicine. Originally from India, Dr. Parikh attended medical school at Seth G.S. Medical College and KEM Hospital in Mumbai. He completed his fellowship in Nephrology and Hypertension and UNOS Transplant Certification at the University of Colorado, under the mentorship of Dr. Robert Schrier. While completing his fellowship, he also earned a doctorate in Clinical Investigation.
Dr. Parikh has several active NIH grants, has published over 500 original articles, and has been cited over 50,000 times in literature. His research focuses on the translation and validation of novel biomarkers for the diagnosis and prognosis of acute kidney injury (AKI). Dr. Parikh is the driving force in a series of discoveries contributing to groundbreaking progress in clinical care for acute kidney injury and setting the stage for creating novel treatment paradigms, based on phenotyping with novel proteins of injury, inflammation, and repair to eliminate the global epidemic of AKI. He followed up these discoveries with a series of paradigm-shifting multicenter studies that generated evidence for these proteins for various clinical applications in perioperative of AKI, hepatorenal syndrome, reducing discard in perioperative AKI, and cardiorenal syndrome. At Johns Hopkins, Dr. Parikh directs the Precision Medicine Center of Excellence for Kidney Diseases, leading transformative changes in clinical care and research studies.

Dr. Parikh received the Young Investigator Award from the American Society of Nephrology in 2017, was inducted into the ASCI society in 2018, and was elected to the AAP in 2021. He is a renowned speaker, presenting at universities and conferences all over the world, and an esteemed mentor who has proven valuable to students, postdoctoral fellows, and faculty.

Dr. Jeffrey Perl is a staff nephrologist at St. Michael’s Hospital in Toronto and a Professor of Medicine at the University of Toronto. He has recently been awarded The J. Michael Lazarus distinguished award from the US National Kidney Foundation, a Mid-Career Leadership Award from the American Society of Nephrology and the John Maher Young Investigator Award from the International Society for Peritoneal Dialysis, along with several teaching and mentorship awards at both the University of Toronto and St. Michael’s Hospital.

Dr. Perl’s primary research interests, clinical practice, and teaching focus on enhancing universal access to and improving clinical outcomes in home dialysis. He serves as the editor-in-chief of Peritoneal Dialysis International and co-chaired the KDIGO Home Dialysis Controversies Conference. He has delivered numerous invited lectures and authored multiple peer-reviewed publications and book chapters.

As the principal investigator for the International Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS), Dr. Perl also co-led the Optimizing the Prevention of Peritoneal Dialysis-Associated Peritonitis in the United States (OPPUS) study. He is a faculty member at Home Dialysis University and co-supervises the Home Dialysis Fellowship at St. Michael’s Hospital. Additionally, he co-chairs the American Society of Nephrology’s home dialysis steering committee and previously chaired the ASN COVID-19 response team’s home dialysis subcommittee.

Rebecca J. Schmidt is a nephrologist with 32 years of experience as a rural practitioner, inpatient and outpatient clinician, teacher, division leader, assistant dean, dialysis medical director, and patient and physician advocate. After residency and fellowship training at Henry Ford Hospital in Detroit, she moved to Morgantown, West Virginia in 1993 where she found her passion in rural outreach and advocacy. During her 17-year tenure as Chief of Nephrology at West Virginia University School of Medicine, she led the initiative to decentralize the nephrology outpatient clinic system, expanding its reach to patients from more than 24 West Virginia counties through the development of 12 clinic sites for chronic kidney disease care and growth of the dialysis program to 12 regional facilities. Dr. Schmidt served as (the first and only woman) President of the Renal Physicians Association and as a member of boards, forums, committees, task forces, technical expert panels and initiatives related to advocacy related to kidney disease. She led a statewide effort to increase public awareness about kidney disease through screenings, continuing education and annual conferences dedicated to primary care of kidney disease, and led the development of NephRefTM, a digital application created for rural providers of patients with kidney diseases. She continues to care for patients across north central West Virginia.

Dr. Schmidt serves as Assistant Dean for Outreach and Community Engagement for West Virginia University School of Medicine and as Senior Advisor to the Chair of the Department of Medicine. In 2005, Dr. Schmidt received the West Virginia University School of Medicine Dean’s Award for Excellence in Community Service. In 2006, she was honored as a Local Legend among West Virginia University Women Who Made a Difference. She received the Ethel and Gerry Heebink Award for Distinguished State Service (Extended) in 2007 and the Gift of Life Award from the National Kidney Foundation of the Alleghenies in 2008, the WVU Health Sciences Women in Science and Health Advanced Career Excellence Award in 2016, the American Association of Kidney Patients Medal of Excellence in 2018, and the Renal Physicians Association Distinguished Nephrologist Service Award in 2022.

Dr. Jeffrey Silberzweig is a nephrologist in New York, NY, and is affiliated with New York – Presbyterian/Weill Cornell and New York-Presbyterian/Lower Manhattan Hospital. He received his medical degree from the University of Buffalo, School of Medicine and Biomedical Sciences and completed his internal medicine residency at Beth Israel Medical Center, Mount Sinai School of Medicine and his nephrology fellowship at the University of Pennsylvania. Dr. Silberzweig has been in practice for 30 years. He has extensive experience in general nephrology and dialysis. His research interests include the impact of social determinants of health on patients with kidney disease. Dr. Silberzweig is currently the Chief Medical Officer of The Rogosin Institute. He is also Professor of Clinical Medicine, and Clinical Medicine in Surgery, Weill Cornell Medical College. Dr. Silberzweig is chair of ASN’s Humanitarian Kidney Support Program and co-chair of ASN’s Current and Emerging Threats Workgroup. He represents ASN on the ASN-ERA-ISN Kidney Support Initiative.

Quin is a kidney disease survivor and a Board Certified Patient Advocate.  She was on in-center hemodialysis at the University of Chicago, training for home dialysis, when she received the call to receive a kidney transplant.  Quin is a patient advocate, using her voice to improve the care and safety of kidney patients.  She has started a company, Tayloring Gratitude to share her message of hope with others.

Katherine R. Tuttle, MD, FASN, FACP, FNKF, is Executive Director for Research at Providence Inland Northwest Health and Professor of Medicine at the University of Washington. Dr. Tuttle earned her medical degree and completed her residency in Internal Medicine at Northwestern University in Chicago. She was a fellow in Metabolism and Endocrinology at Washington University in St. Louis. Her Nephrology fellowship training was performed at the University of Texas Health Science Center in San Antonio.

Dr. Tuttle’s major research interests are in diabetes and CKD. As a clinical and translational scientist, her seminal work in physiological and pre-clinical studies laid a foundation for new therapies. Over more than three decades, she helped to deliver SGLT2 inhibitors and GLP-1 receptor agonists as novel agents to reduce risks of kidney failure, cardiovascular disease, and death in the CKD population with or without diabetes. She has also been a leading investigator for other therapeutic breakthroughs, including next generation incretin, anti-inflammatory, and aldosterone agents. Additionally, she leads the CURE-CKD Registry of real-world data for CKD, diabetes, and hypertension from >6 million health system patients.

Dr. Tuttle chairs the Diabetic Kidney Disease Collaborative and served on the inaugural Board of Directors for the Kidney Health Initiative for the American Society of Nephrology. She has chaired many initiatives for the National Institutes of Health, the International Society of Nephrology, Kidney Disease Improving Global Outcomes, the National Kidney Foundation, and the American Diabetes Association. Dr. Tuttle has received many honors and awards including the John P. Peters Lifetime Achievement Award from the American Society of Nephrology, the Medal of Excellence from the American Association of Kidney Patients, the Garabed Eknoyan Award from the National Kidney Foundation, the YWCA Woman of Achievement Award in Science, and two University of Washington Outstanding Clinical Faculty Awards.

Bradley A. Warady, MD is Professor of Pediatrics at the University of Missouri-Kansas City School of Medicine; Director, Division of Nephrology and Director, Dialysis and Transplantation at Children’s Mercy Kansas City. Dr. Warady serves as Co-Principal Investigator of the NIH-funded Chronic Kidney Disease in Children (CKiD) Study and the International Pediatric Dialysis Network (IPDN). He is Vice President, Board of Directors of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS), Member, Nephrologists Transforming Dialysis Safety (NTDS) committee, Governing Board Member of the Midwest Transplant Network (MTN), National Board Member for the National Kidney Foundation, and Treasurer of the International Pediatric Nephrology Association (IPNA).

Dr. Wong is a graduate of the University of Texas Southwestern Medical School. He completed his medicine residency, chief residency, and nephrology fellowship training at the University of North Carolina. He serves as the System Executive Medical Director of Medicine at Rochester Regional Health (RRH), a nine-hospital health system in Western New York. In this role, he leads RRH’s largest service line, comprised of eight specialty divisions, two internal medicine residency programs, and four subspecialty fellowship programs.

Dr. Wong is a seasoned nephrologist and healthcare executive, with successful leadership roles in several notable healthcare organizations. He started his career as Medical Director of Peritoneal Dialysis at Northwest Kidney Centers in Seattle, then became Satellite Healthcare’s Vice President of Clinical Affairs. He then joined Cleveland Clinic, where he was Associate Medical Director of the Medicare Accountable Care Organization, Vice-Chairman of Nephrology and Hypertension with emphasis on Clinical Transformation, Director of Dialysis and End-Stage Renal Disease, and Associate Professor of Medicine at Case Western Reserve University.

Dr. Wong then became Chief Medical Officer of Nephrology Care Alliance, a division of DaVita Inc. where he led efforts to educate and prepare nephrologists for the Kidney Care Choices model and DaVita’s value-based kidney programs. Prior to joining RRH, he was Intermountain Health’s Senior Medical Director of Kidney Services and Chief Kidney Health Officer. In this capacity, Dr. Wong led Intermountain’s efforts to deliver nationally-recognized care delivery, with an emphasis on reducing the incidence of kidney failure and improving kidney health across the Mountain West region of the U.S.
Dr. Wong is a past member of the ASN Dialysis Advisory Group and former Chair of Quality Assessment, Improvement, and Education for Nephrologists Transforming Dialysis Safety (NTDS) and currently participates in the ASN Diabetic Kidney Disease Collaborative.